Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. Crohn’s & Colitis Foundation Perspectives

Special Diagnostic Considerations for Inflammatory Bowel Disease

ReachMD Healthcare Image
Restart
Resume
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Comments
  • In Collaboration with

  • Overview

    Making an appropriate diagnosis of inflammatory bowel disease (IBD) requires a variety of laboratory tests, serologic studies, imaging techniques and procedures such as endoscopies, and biopsies. While many methods are widely used when IBD is suspected based on symptoms and history, some confusion persists around newer diagnostic modalities such as MRE and capsule endoscopies, as well as the utility of emerging serologic biomarker tests. Additionally, uncommon presentations of IBD such as asymptomatic ileitis further complicate diagnostic workups.   

    On this episode, Laura Wingate, Vice President of Education, Support, and Advocacy at the Crohn’s & Colitis Foundation, joins gastroenterologist Dr. David Binion, Co-Director at the IBD Center on Translational Research and Director of Nutrition Support Service at the University of Pittsburgh. The two discuss special diagnostic considerations for patients with IBD. 

  • Publication Date

    Release Date: 03/06/2017

Recommended
Details
Comments
  • In Collaboration with

  • Overview

    Making an appropriate diagnosis of inflammatory bowel disease (IBD) requires a variety of laboratory tests, serologic studies, imaging techniques and procedures such as endoscopies, and biopsies. While many methods are widely used when IBD is suspected based on symptoms and history, some confusion persists around newer diagnostic modalities such as MRE and capsule endoscopies, as well as the utility of emerging serologic biomarker tests. Additionally, uncommon presentations of IBD such as asymptomatic ileitis further complicate diagnostic workups.   

    On this episode, Laura Wingate, Vice President of Education, Support, and Advocacy at the Crohn’s & Colitis Foundation, joins gastroenterologist Dr. David Binion, Co-Director at the IBD Center on Translational Research and Director of Nutrition Support Service at the University of Pittsburgh. The two discuss special diagnostic considerations for patients with IBD. 

  • Publication Date

    Release Date: 03/06/2017

Schedule23 Nov 2024